NK cells in the brain: implications for brain tumor development and therapy

Area of Science:

• Immunology
• Neuro-oncology
• Cellular Therapy

Background:

• Natural killer (NK) cells are innate lymphoid cells with significant antitumor capabilities.
• NK cells are increasingly recognized for their role in central nervous system (CNS) pathophysiology, despite being a minor component of brain tumor-infiltrating immune cells.
• The brain's immunosuppressive microenvironment and tumor resistance pose challenges for effective NK cell-based cancer therapy.

Purpose of the Study:

• To review the role of NK cells in the pathogenesis of primary and metastatic brain tumors.
• To discuss strategies for enhancing NK cell therapeutic potential against CNS malignancies.
• To summarize preclinical and clinical evidence of NK cell-based therapies for brain tumors.

Main Methods:

• Literature review of preclinical studies and clinical trials.
• Analysis of NK cell functions in the CNS tumor microenvironment.
• Evaluation of novel approaches to augment NK cell-mediated cytotoxicity.

Main Results:

• NK cells possess inherent antitumor functions relevant to brain malignancies.
• Various strategies are being investigated to overcome the challenges of CNS tumor treatment with NK cells.
• Engineering approaches and combination therapies show potential for improving NK cell efficacy.

Conclusions:

• NK cell-based therapies represent a promising avenue for treating primary and metastatic brain tumors.
• Further research and clinical trials are needed to optimize NK cell therapy in the CNS.
• Harnessing NK cell potential requires addressing the unique challenges of the brain tumor microenvironment.